Search results
PROMOTED
Author(s):
Nicolas M Van Mieghem
,
Kendra J Grubb
,
David Hildick-Smith
,
et al
Start date:
Mar 26, 2024
Author(s):
Andrea Pacchioni
,
Dimitris Nikas
,
Carlo Penzo
,
et al
Added:
3 years ago
Transcatheter aortic valve implantation (TAVI) and endovascular aortic repair (EVAR) are increasingly being used as therapeutic options for patients with severe aortic stenosis ineligible for surgery and with aortic aneurysm with suitable anatomical features. Despite encouraging results from randomised studies and registries regarding the pursuit of endovascular treatment in selected patients,…
View more
Author(s):
Giovanni Luigi De Maria
,
Adrian P Banning
Added:
3 years ago
Detection of obstructive disease of the left main coronary artery (LMCA) is relatively unusual in the catheterisation laboratory, as it accounts for approximately 4 % of all coronary angiograms, with isolated LMCA disease observed in only 5–10 % of these cases.1
Intervention to the LMCA is, however, notable compared to the treatment of coronary stenosis elsewhere in the coronary tree. First,…
View more
Author(s):
Angela Hoye
Added:
3 years ago
The coronary tree is comprised of arteries which divide into ever smaller branches to supply the myocardium. This means that the diameter of the vessel proximal to a bifurcation is always larger than the diameter of the main vessel distal to the bifurcation. The proximal optimisation technique (POT) was proposed by Dr Olivier Darremont as a technique to compensate for this difference in diameters…
View more
Author(s):
Toby Rogers
Added:
2 years ago
In this interview from CRT 2022, Dr Toby Rogers (MedStar Washington Hospital Center, Washington DC, WA, US) outlines the procedure for transcatheter mitral cerclage ventriculoplasty in patients with mitral regurgitation and either HFrEF or HFpEF. Dr Rogers provides a step-by-step overview of the procedure and presents the outcomes of this early feasibility trial. Results suggest that the TMCA…
View more
Author(s):
Kendra J Grubb
Added:
1 year ago
Dr Kendra Grubb (Emory Structural Heart and Valve Center, GA, US) outlines the interim analysis of the Optimize PRO Study (NCT04091048), originally presented at EuroPCR 2022.
Optimize PRO aimed to evaluate valve performance and procedural outcomes of optimised TAVR care using Medtronic's Evolut™ PRO and Evolut™ PRO+ devices.
Findings are promising and show that no patients experienced a…
View more
ELCA to Treat Calcified Lesions
Author(s):
Silvio Vera-Vera
,
Artemio Garcia
,
Santiago Jimenez-Valero
,
et al
Added:
1 year ago
Article
Author(s):
Alfredo Galassi
,
Aaron Grantham
,
David Kandzari
,
et al
Added:
3 years ago
Section A
Techniques for Chronic Total Occlusions Revascularisation
Access Route, Guiding Catheter Selection and Contralateral Injection
The femoral approach is the preferred access route by most operators. However, the radial approach might be chosen because of severe peripheral vascular disease, operator’s preference or for contralateral injection. The guiding principle of access selection is…
View more
Author(s):
Vijay S Ramanath
,
Craig Thompson
Added:
3 years ago
Coronary chronic total occlusions (CTOs) remain one of the most challenging percutaneous challenges in interventional cardiology, with technical success rates of only ~50–70 %.1,2 This lesion subset often poses the greatest risk and often requires techniques and equipment not typically utilised for more acute coronary lesions. However, successful percutaneous CTO revascularisation is associated…
View more
Author(s):
Nicolas Foin
,
Eduardo Alegria-Barrero
,
Ryo Torii
,
et al
Added:
3 years ago
Drug-eluting stents (DESs) have contributed to a significant lowering of the incidence of restenosis and target vessel revascularisation (TVR) in bifurcations.1–4 A randomised study of bifurcation lesions using sirolimus-eluting stents revealed restenosis rates of only 4 % in the main branch (MB) and a TVR rate as low as 8.2 % at six-month follow-up,2 a marked improvement over that in historical…
View more